Skip to content
10-Q

Quarterly Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000810

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Dec 16, 2022 78.36M sh
Operating Cash Flow Q2 2018 · Mar 31, 2019 −$1.68K
Operating Cash Flow Q2 2018 · Mar 31, 2018 −$21.55K
Stockholders Equity Q2 2018 · Mar 31, 2019 −$227.59K
Stockholders Equity Q2 2018 · Dec 31, 2018 −$223.95K
Stockholders Equity Q2 2018 · Sep 30, 2018 −$221.09K
Stockholders Equity Q2 2018 · Mar 31, 2018 −$209.7K
Stockholders Equity Q2 2018 · Dec 31, 2017 −$200.31K
Stockholders Equity Q2 2018 · Sep 30, 2017 −$192.69K
Current Liabilities Q2 2018 · Mar 31, 2019 $228.18K
Current Liabilities Q2 2018 · Sep 30, 2018 $223.36K
Total Liabilities Q2 2018 · Mar 31, 2019 $228.18K
Total Liabilities Q2 2018 · Sep 30, 2018 $223.36K
Current Assets Q2 2018 · Mar 31, 2019 $587
Current Assets Q2 2018 · Sep 30, 2018 $2.27K
Total Assets Q2 2018 · Mar 31, 2019 $587
Total Assets Q2 2018 · Sep 30, 2018 $2.27K
Net Income Q2 2018 · Mar 31, 2019 −$3.64K
Net Income Q2 2018 · Mar 31, 2019 −$6.5K
Net Income Q2 2018 · Dec 31, 2018 −$2.86K
Net Income Q2 2018 · Mar 31, 2018 −$9.39K
Net Income Q2 2018 · Mar 31, 2018 −$17.02K
Net Income Q2 2018 · Dec 31, 2017 −$7.63K
Operating Income Q2 2018 · Mar 31, 2019 −$2.73K
Operating Income restated Q2 2018 · Mar 31, 2018 −$8.19K
Operating Income restated Q2 2018 · Mar 31, 2018 −$15.21K